Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers.
about
Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VIIWarfarin Dose Model for the Prediction of Stable Maintenance Dose in Indian Patients.VKORC1 polymorphisms and warfarin maintenance dose in population of Sakha (Yakuts).
P2860
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Factor VII R353Q genetic polym ...... y among CYP2C9 *1/*1 carriers.
@en
Factor VII R353Q genetic polym ...... y among CYP2C9 *1/*1 carriers.
@nl
type
label
Factor VII R353Q genetic polym ...... y among CYP2C9 *1/*1 carriers.
@en
Factor VII R353Q genetic polym ...... y among CYP2C9 *1/*1 carriers.
@nl
prefLabel
Factor VII R353Q genetic polym ...... y among CYP2C9 *1/*1 carriers.
@en
Factor VII R353Q genetic polym ...... y among CYP2C9 *1/*1 carriers.
@nl
P2093
P2860
P1476
Factor VII R353Q genetic polym ...... y among CYP2C9 *1/*1 carriers.
@en
P2093
Idit Bejarano-Achache
Liat Mlynarsky
Yoseph Caraco
P2860
P2888
P304
P356
10.1007/S00228-011-1143-Z
P577
2011-11-10T00:00:00Z